Analytical Sciences

Human Serum Albumin-modified Fe₃O₄ Magnetic Nanoparticles for Affinity-SALDI-MS of Small-Molecule Drugs in Biological Liquids

Yuichi IWAKI, Hideya KAWASAKI, and Ryuichi ARAKAWA

Department of Chemistry and Materials Engineering, Faculty of Chemistry, Materials and Bioengineering, Kansai University, 3-3-35 Yamate, Suita, Osaka 564-8680, Japan

Here, we report on the use of human serum albumin (HSA)-modified Fe₃O₄ nanoparticles (NPs) (HSA-Fe₃O₄ NPs) for affinity-SALDI-MS of small drugs in human biological liquids. We demonstrated that HSA-Fe₃O₄ NPs effectively captured small drugs from human urine and serum via the interactions between HSA and these drugs. The drugs adsorbed on HSA could then be identified by directly introducing the HSA-Fe₃O₄ NPs into a mass spectrometer for SALDI-MS analysis. The ability of HSA to interact with multiple small drugs facilitated the simultaneous detection of a 4-drug-mixture in serum, viz., phenytoin, ibuprofen, camptothecin, and warfarin sodium, by affinity-SALDI-MS using HSA-Fe₃O₄ NPs. In contrast, matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) with an organic matrix could detect only warfarin sodium. We also demonstrated the capacity of affinity-SALDI-MS to quantify warfarin sodium in urine samples across a range of 50 – 1000 μM (R² = 0.998) when using HSA-Fe₃O₄ NPs. The detection sensitivity was further improved to a range of 5 – 100 μM (R² = 0.999) by using denatured HSA. The open structure of denatured HSA may enhance the effective extraction of small drugs from biological liquids, and increase the detection-sensitivity of affinity-SALDI-MS. Affinity-SALDI-MS using protein-modified Fe₃O₄ NPs can open up new approaches to the analytical detection of small drugs in biological liquids by SALDI-MS.

J-STAGE: View this article in J-STAGE